4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001193125-26-452132
Director bought 91,806 shares at an average $381.49 ($35,023,032)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP Director | 2026-11-04 | Purchase | +5,586 | $366.99 | $2,050,018 | 1,954,462 | I |
| BAKER BROS. ADVISORS LP Director | 2026-11-04 | Purchase | +10,080 | $368.11 | $3,710,583 | 1,964,542 | I |
| BAKER BROS. ADVISORS LP Director | 2026-11-06 | Purchase | +60,400 | $383.02 | $23,134,106 | 2,024,942 | I |
| BAKER BROS. ADVISORS LP Director | 2026-11-06 | Purchase | +13,740 | $388.29 | $5,335,105 | 2,038,682 | I |
| BAKER BROS. ADVISORS LP Director | 2026-11-06 | Purchase | +2,000 | $396.61 | $793,220 | 2,040,682 | I |
| Open-market purchases · 91,806 sh · avg $381.49 · $35,023,032 | |||||||
Loading xslF345X06/ownership.xml…